Clinical Benefits for Patients FDA-approved GLP-1 injections offer multiple advantages for patients struggling with diabetes or weight management, as demonstrated in clinical trials of the approved products: Effective glycemic control without increased hypoglycemia risk Significant and sustained weight reduction demonstrated in clinical trials of approved GLP-1 medications (see approved prescribing information for specific products) Reduced cardiovascular risk factors and events Improvement in liver health for patients with non-alcoholic fatty liver disease Enhanced quality of life through better disease management and reduced complication risk Potential neuroprotective effects being investigated in ongoing research Note: Clinical outcomes cited above reflect published trial data for FDA-approved GLP-1 receptor agonists
The bottom line: sermorelin should only be used if you have a diagnosable growth hormone deficiency or a related medical condition
PlexusDx Semaglutide for Personalized PWS Management PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, formulated by licensed 503A compounding pharmacies to meet individual patient needs
Baseline Biomarker Assessment: The Foundation for Safe Dual Therapy Before starting testosterone with a GLP-1 medication, comprehensive baseline bloodwork should include: testosterone, estradiol, FSH/LH, fasting glucose, HbA1c, lipid panel, liver and kidney function, hematocrit, and thyroid markers
ColonBroom appears to be a legitimate supplement with both strengths and weaknesses
.jpg)
